154 related articles for article (PubMed ID: 32070824)
1. Decellularized liver as a translucent ex vivo model for vascular embolization evaluation.
Gao Y; Li Z; Hong Y; Li T; Hu X; Sun L; Chen Z; Chen Z; Luo Z; Wang X; Kong J; Li G; Wang HL; Leo HL; Yu H; Xi L; Guo Q
Biomaterials; 2020 May; 240():119855. PubMed ID: 32070824
[TBL] [Abstract][Full Text] [Related]
2. Cirrhotic hepatocellular carcinoma-based decellularized liver cancer model for local chemoembolization evaluation.
Wang M; Gao Y; Liu X; Li Z; Xiao J; Gao X; Gibson MI; Guo Q
Acta Biomater; 2024 Mar; 176():144-155. PubMed ID: 38244660
[TBL] [Abstract][Full Text] [Related]
3. Visualization and Evaluation of Chemoembolization on a 3D Decellularized Organ Scaffold.
Gao X; Chen Z; Chen Z; Liu X; Luo Y; Xiao J; Gao Y; Ma Y; Liu C; Leo HL; Yu H; Guo Q
ACS Biomater Sci Eng; 2021 Dec; 7(12):5642-5653. PubMed ID: 34735119
[TBL] [Abstract][Full Text] [Related]
4. Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.
Gomes AS; Rosove MH; Rosen PJ; Amado RG; Sayre JW; Monteleone PA; Busuttil RW
AJR Am J Roentgenol; 2009 Dec; 193(6):1665-71. PubMed ID: 19933662
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Sol-Gel Reaction of Tantalum Alkoxide for Endovascular Embolization.
Ko G; Choi JW; Shin K; Kim YG; Kang T; Kim D; Lee N; Kim HC; Hyeon T
Adv Healthc Mater; 2022 Feb; 11(4):e2101908. PubMed ID: 34783195
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization.
Negussie AH; Dreher MR; Johnson CG; Tang Y; Lewis AL; Storm G; Sharma KV; Wood BJ
J Mater Sci Mater Med; 2015 Jun; 26(6):198. PubMed ID: 26105830
[TBL] [Abstract][Full Text] [Related]
7. Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future.
Woo HY; Heo J
Clin Mol Hepatol; 2015 Dec; 21(4):344-8. PubMed ID: 26770921
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Embolization Efficacy with the Embolic Microspheres Guided by the Aggregate Gradation Theory Through In Vitro and Simulation Evaluation.
Huang D; Chen Z; Yang Y; Jiang L; Liu Y; Yang Y; Zhang C
Cardiovasc Eng Technol; 2021 Aug; 12(4):398-406. PubMed ID: 33844137
[TBL] [Abstract][Full Text] [Related]
9. Chemoembolization for hepatocellular carcinoma.
Lencioni R
Semin Oncol; 2012 Aug; 39(4):503-9. PubMed ID: 22846867
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion.
de Baere T; Arai Y; Lencioni R; Geschwind JF; Rilling W; Salem R; Matsui O; Soulen MC
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):334-43. PubMed ID: 26390875
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization for unresectable hepatocellular carcinoma: A comparison of the efficacy and safety of 2 embolic agents.
Chen S; Yu W; Zhang K; Liu W; Chen Q
Medicine (Baltimore); 2018 May; 97(21):e10832. PubMed ID: 29794774
[TBL] [Abstract][Full Text] [Related]
12. Liver chemoembolization of hepatocellular carcinoma using TANDEM
Delicque J; Guiu B; Boulin M; Schwanz H; Piron L; Cassinotto C
Future Oncol; 2018 Nov; 14(26):2761-2772. PubMed ID: 29953255
[TBL] [Abstract][Full Text] [Related]
13. Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality.
Kim DY; Han KH
Hepatol Int; 2016 Nov; 10(6):883-892. PubMed ID: 27126821
[TBL] [Abstract][Full Text] [Related]
14. TACE versus TAE as therapy for hepatocellular carcinoma.
Pleguezuelo M; Marelli L; Misseri M; Germani G; Calvaruso V; Xiruochakis E; Manousou P; Burroughs AK
Expert Rev Anticancer Ther; 2008 Oct; 8(10):1623-41. PubMed ID: 18925854
[TBL] [Abstract][Full Text] [Related]
15. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
[TBL] [Abstract][Full Text] [Related]
16. Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: a cross-sectional survey of techniques.
Young S; Craig P; Golzarian J
Eur Radiol; 2019 Jun; 29(6):3287-3295. PubMed ID: 30350163
[TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma.
Nam HC; Jang B; Song MJ
World J Gastroenterol; 2016 Oct; 22(40):8853-8861. PubMed ID: 27833376
[TBL] [Abstract][Full Text] [Related]
18. Current Trends in the Treatment of Hepatocellular Carcinoma with Transarterial Embolization: Variability in Technical Aspects.
Craig P; Young S; Golzarian J
Cardiovasc Intervent Radiol; 2019 Sep; 42(9):1322-1328. PubMed ID: 31087146
[TBL] [Abstract][Full Text] [Related]
19. Transarterial Embolization for Hepatocellular Carcinoma: A Comparison between Nonspherical PVA and Microspheres.
Scaffaro LA; Kruel CD; Stella SF; Gravina GL; Machado Filho G; Borges de Almeida CP; Pinto LC; Alvares-da-Silva MR; Kruel CR
Biomed Res Int; 2015; 2015():435120. PubMed ID: 26413523
[TBL] [Abstract][Full Text] [Related]
20. Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art.
Facciorusso A
World J Gastroenterol; 2018 Jan; 24(2):161-169. PubMed ID: 29375202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
